IT1255969B - Formulazioni di acido ursodesossicolico a rilascio controllato - Google Patents

Formulazioni di acido ursodesossicolico a rilascio controllato

Info

Publication number
IT1255969B
IT1255969B ITMI922722A ITMI922722A IT1255969B IT 1255969 B IT1255969 B IT 1255969B IT MI922722 A ITMI922722 A IT MI922722A IT MI922722 A ITMI922722 A IT MI922722A IT 1255969 B IT1255969 B IT 1255969B
Authority
IT
Italy
Prior art keywords
controlled release
ursodexoxylic
acid formulations
ursodeoxycholic acid
acid
Prior art date
Application number
ITMI922722A
Other languages
English (en)
Inventor
Pasquale Pantisano
Original Assignee
Pasquale Pantisano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasquale Pantisano filed Critical Pasquale Pantisano
Priority to ITMI922722A priority Critical patent/IT1255969B/it
Publication of ITMI922722A0 publication Critical patent/ITMI922722A0/it
Publication of ITMI922722A1 publication Critical patent/ITMI922722A1/it
Application granted granted Critical
Publication of IT1255969B publication Critical patent/IT1255969B/it

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composizioni farmaceutiche e rilascio controllato di acido ursodesossicolico per somministrazione orale, comprendenti acido ursodesossicolico in forma micronizzate e idrossipropilmetilcellulosa ed inoltre sostanze leganti, diluenti e lubrificanti.
ITMI922722A 1992-11-27 1992-11-27 Formulazioni di acido ursodesossicolico a rilascio controllato IT1255969B (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI922722A IT1255969B (it) 1992-11-27 1992-11-27 Formulazioni di acido ursodesossicolico a rilascio controllato

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922722A IT1255969B (it) 1992-11-27 1992-11-27 Formulazioni di acido ursodesossicolico a rilascio controllato

Publications (3)

Publication Number Publication Date
ITMI922722A0 ITMI922722A0 (it) 1992-11-27
ITMI922722A1 ITMI922722A1 (it) 1994-05-27
IT1255969B true IT1255969B (it) 1995-11-17

Family

ID=11364370

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922722A IT1255969B (it) 1992-11-27 1992-11-27 Formulazioni di acido ursodesossicolico a rilascio controllato

Country Status (1)

Country Link
IT (1) IT1255969B (it)

Also Published As

Publication number Publication date
ITMI922722A0 (it) 1992-11-27
ITMI922722A1 (it) 1994-05-27

Similar Documents

Publication Publication Date Title
MY121733A (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole-3-carboxamide derivative, its salts and their solvates
AU1639497A (en) Methods for preventing or inhibiting bone loss with 3,4-diarylchroman
WO1999053910A3 (en) Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
AU2274201A (en) Compounds and compositions for delivering active agents
DE69620877T2 (de) Arzneimittelformulierungen für il-12
ATE192153T1 (de) Amino-imidazo (4,5-c) chinoline
IL195055A0 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
DE69430237T2 (de) Arzneimittel zur gesteuerten Freisetzung
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
MY115351A (en) Pharmaceutical formulations
FI970164A0 (fi) Inhalaatioformula
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
FI945081A0 (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
MY100998A (en) Pharmaceutical formulations
ATE275974T1 (de) Zusammensetzungen enthaltend glykolderivate, alkohole und vitamin d
DE60020570D1 (de) Rotavirus impfstoffformulierungen
AR061005A2 (es) Forma cristalina a de 1-(2,6- difluorobencil)-1h-1,2,3- triazol-4-carboxamida, preparaciones farmaceuticas que las contienen y su uso para la preparacion de medicamentos
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
FI972434A (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
AU1354495A (en) Formulations for orally administered pharmaceutical agents
GR3024611T3 (en) 8-ENE-19, 11 beta-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM
IT1255969B (it) Formulazioni di acido ursodesossicolico a rilascio controllato

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971128